🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Ewing Sarcoma

A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors NCT06926283Phase 14 sites📍 Changsha📍 Hangzhou📍 Beijing Hangzhou DAC Biotechnology Co., Ltd. · Tests: DXC008 Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery NCT05779670n/a1 site📍 Bologna Istituto Ortopedico Rizzoli Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone NCT05033288n/a3 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Electronic Health Record Review, Quality-of-Life Assessment Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites📍 Washington D.C.📍 Baltimore📍 Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Consolidative radiation therapy (cRT) Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) NCT06395103Phase 1, Phase 271 sites📍 Los Angeles📍 Aurora📍 New Haven Merck Sharp & Dohme LLC · Tests: Zilovertamab vedotin Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas NCT05210374Phase 11 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites📍 San Francisco📍 Aurora📍 Philadelphia Children's Hospital of Philadelphia · Tests: Cabozantinib Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites📍 Los Angeles📍 Los Angeles📍 Baltimore Amgen · Tests: Xaluritamig Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma NCT06243588n/a1 site📍 Bologna Istituto Ortopedico Rizzoli · Tests: clinical records review Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors NCT07628634EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Methionine-Reduced Diet B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas NCT04055220NA16 sites📍 Besançon📍 Bordeaux📍 Lille Centre Leon Berard · Tests: Treatment by Regorafenib, Surveillance Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma NCT06340204Phase 13 sites📍 Jina📍 Beijin📍 Beijing Peking University People's Hospital · Tests: Irinotecan Hydrochloride Liposome Injection Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma NCT06827717Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: irinotecan liposome (II) + temozolomide + fluzoparib DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma NCT06892678Phase 1, Phase 21 site📍 The Bronx Montefiore Medical Center · Tests: DFMO Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas NCT05182164Phase 210 sites📍 Bordeaux📍 Dijon📍 Lille Institut Bergonié · Tests: Association of pembrolizumab + cabozantinib Lurbinectedin in FET-Fused Tumors NCT05918640Phase 1, Phase 26 sites📍 Los Angeles📍 Iowa City📍 Boston Children's Hospital of Philadelphia · Tests: Lurbinectedin Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites📍 Baltimore📍 The Bronx📍 Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma NCT07321912Phase 23 sites📍 Tampa📍 Portland📍 Hershey Milton S. Hershey Medical Center · Tests: Eflornithine, Topotecan, Cyclophosphamide, Vincristine, Doxorubicin Molecular Analysis Of Solid Tumors NCT01050296n/a1 site📍 Memphis St. Jude Children's Research Hospital A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma NCT06564272Phase 21 site📍 Beijing Beijing Konruns Pharmaceutical Co., Ltd. · Tests: KC1036 Single Arm Romiplostim to Prevent CIT NCT07048249EARLY Phase 12 sites📍 Phoenix📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Romiplostim (AMG-531) Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method NCT07141862n/a1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: RT-qPCR, ddPCR A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites📍 Duarte📍 Newport Beach📍 Boston SEED Therapeutics, Inc. · Tests: ST-01156 Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse NCT04758000Phase 21 site📍 Bologna Istituto Ortopedico Rizzoli · Tests: Metformin Hydrochloride A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma NCT07725783n/a1 site📍 Beijing Peking University People's Hospital XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy